HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors
1 clinical trials · Condition
◉ Watch HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors
| Record | Firm | Date |
|---|---|---|
| SHR-4602 for Injection in Subjects With HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors (NCT06516926) | Jiangsu HengRui Medicine Co., Ltd. | 2024-08-08 |
Track HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.